You are here: Industry Insights > AMR

News List

The ongoing AMR challenge Suzanne Elvidge
May 06, 2024
The development of antimicrobial agents has saved many lives worldwide since the discovery of penicillin in 1928.
Evolving World of Pharma: A Post-pandemic Future Sarah Harding
April 27, 2020
The COVID-19 pandemic has had an unprecedented impact on our world. As many countries reach or pass their ‘peak’, we are all asking the same questions – what does the future hold, when will we get back to normal…. and what will that ‘normal’ be?
An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections Pharmaceutical-Technology
January 24, 2022
More than 1.2 million people - and potentially millions more - died in 2019 as a direct result of antibiotic-resistant bacterial infections, according to the most comprehensive estimate to date of the global impact of antimicrobial resistance (AMR).
The Lancet warns of 'overlooked pandemic of antimicrobial resistance' in new study CPhIonline
January 21, 2022
The medical journal highlights antimicrobial resistance (AMR) to be a 'leading cause of death around the world'.
White paper calls for action on AMR expresspharma
July 30, 2021
A group of researchers led by Professor Nirmal Kumar Ganguly, Former Director-General, Indian Council of Medical Research (ICMR), have come out with a white paper on AMR, as it threatens to become the next big public health crisis in India and ...
EU to support novel antibiotics with €20 million funding europeanpharmaceuticalreview
April 15, 2021
BioVersys will receive €20 million in funding to support its development of new treatments for antimicrobial resistant infections.
BioVersys Gets EIB Funds to Address Antimicrobial Resistance contractpharma
April 15, 2021
The European Investment Bank (EIB) and BioVersys AG, a clinical-stage pharmaceutical company developing treatments for multidrug-resistant bacterial infections, signed a €20 million venture debt transaction.
Cipla Therapeutics and SIGA Technologies enter into strategic partnership expresspharma
March 24, 2021
The partnership is to support innovation and provide access to novel antibacterial drugs against biothreats.
INEOS, Oxford University to set up institute for antimicrobial research expresspharma
January 20, 2021
INEOS donates £100 million to Oxford Univerity to set up the new institute to fight antimicrobial resistance.
Effective effluent management: Key to tackle AMR expresspharma
December 29, 2020
As the world adjusts to the post-COVID-19 reality, it is time to reflect and reset. It cannot be ‘business as usual’ in the struggle to survive.

Previous page 1 2 3 Next page